Schwartz Investment Counsel’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Schwartz Investment Counsel’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-240,000	Closed	-$6.16M	–	138
2021 Q2	$6.16M	Hold	240,000	–	–	0.25%	68
2021 Q1	$4.38M	Sell	240,000 -65,000	-21%	-$1.08M	0.19%	69
2020 Q4	$3.52M	Sell	305,000 -25,000	-8%	-$229K	0.16%	70
2020 Q3	$2.52M	Hold	330,000	–	–	0.13%	78
2020 Q2	$2.17M	Sell	330,000 -30,000	-8%	-$167K	0.12%	78
2020 Q1	$1.84M	Hold	360,000	–	–	0.12%	80
2019 Q4	$2.76M	Hold	360,000	–	–	0.13%	77
2019 Q3	$1.91M	Hold	360,000	–	–	0.1%	90
2019 Q2	$2.02M	Hold	360,000	–	–	0.1%	91
2019 Q1	$1.53M	Hold	360,000	–	–	0.08%	95
2018 Q4	$1.48M	Hold	360,000	–	–	0.09%	95
2018 Q3	$2.47M	Sell	360,000 -115,000	-24%	-$682K	0.13%	89
2018 Q2	$1.86M	Hold	475,000	–	–	0.11%	91
2018 Q1	$1.39M	Buy	+475,000	New	+$1.47M	0.08%	99

Other funds holding CDMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Schwartz Investment Counsel's CDMO Position: Q3 2021 in Review

Schwartz Investment Counsel sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2021, closing a stake of 240,000 shares — an estimated $6.16M sold.

Schwartz Investment Counsel first reported a position in CDMO in Q1 2018 and held it in 14 quarters. The position peaked at $6.16M in Q2 2021. 161 funds tracked by Wall St. Rank hold CDMO as of Q3 2021.

Schwartz Investment Counsel reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Schwartz Investment Counsel sold 240,000 Avid Bioservices, Inc. Common Stock shares in Q3 2021, an estimated $6.16M.
Schwartz Investment Counsel first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2018 and held it in 14 quarters.
Schwartz Investment Counsel's Avid Bioservices, Inc. Common Stock position peaked at $6.16M in Q2 2021.
161 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2021.

Based on Schwartz Investment Counsel's 13F filing for Q3 2021, filed 10 Nov 2021.